ghk cu inhibits 5 alpha reductase ✨ How Peptide Works 🚨 Signaling GHK acts as a “switch” for skin repair: Interacts with adenosine receptors → reduces inflammation Activates MAPK/ERK, PI3K/Akt, TGF-β pathways Stimulates fibroblasts & keratinocytes → boosts collagen, elastin The tri-peptide GHK-Cu complex ameliorates

intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention

Well-structured treatments lasting 6-12 months with appropriate concentrations typically maintain noticeable improvements over pre-treatment baseline including reduced fine lines (though not eliminated as during peak treatment), improved skin texture and firmness (though less dramatic than treatment peak), better overall skin quality and appearance (though aging continues at normal rates), and resolved specific issues like scarring or hyperpigmentation (which typically remain improved permanently if successfully treated)

When estrogen levels decline during perimenopause and menopause, skin often thins and loses elasticity at an accelerated rate

Laboratory/In-Vitro Experimental Use Only